Suppr超能文献

N-甲基-D-天冬氨酸受体拮抗作用可损害听觉皮层对言语刺激的感觉门控。

N-methyl-D-aspartate receptor antagonism impairs sensory gating in the auditory cortex in response to speech stimuli.

机构信息

The Royal's Institute of Mental Health Research, Royal Ottawa Mental Health Centre, 1145 Carling Avenue, Ottawa, ON, K1Z 7K4, Canada.

Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.

出版信息

Psychopharmacology (Berl). 2022 Jul;239(7):2155-2169. doi: 10.1007/s00213-022-06090-z. Epub 2022 Mar 28.

Abstract

Deficits in early auditory sensory processing in schizophrenia have been linked to N-methyl-D-aspartate receptor (NMDAR) hypofunction, but the role of NMDARs in aberrant auditory sensory gating (SG) in this disorder is unclear. This study, conducted in 22 healthy humans, examined the acute effects of a subanesthetic dose of the NMDAR antagonist ketamine on SG as measured electrophysiologically by suppression of the P50 event-related potential (ERP) to the second (S2) relative to the first (S1) of two closely paired (500 ms) identical speech stimuli. Ketamine induced impairment in SG indices at sensor (scalp)-level and at source-level in the auditory cortex (as assessed with eLORETA). Together with preliminary evidence of modest positive associations between impaired gating and dissociative symptoms elicited by ketamine, tentatively support a model of NMDAR hypofunction underlying disturbances in auditory SG in schizophrenia.

摘要

精神分裂症早期听觉感觉处理缺陷与 N-甲基-D-天冬氨酸受体 (NMDAR) 功能低下有关,但 NMDAR 在该障碍中异常听觉感觉门控 (SG) 中的作用尚不清楚。本研究在 22 名健康人类中进行,检查了亚麻醉剂量的 NMDAR 拮抗剂氯胺酮对 SG 的急性影响,这是通过抑制 P50 事件相关电位 (ERP) 来测量的,与两个紧密配对的 (500ms) 相同语音刺激的第二个 (S2) 相对于第一个 (S1)。氯胺酮在头皮水平和听觉皮层的源水平 (通过 eLORETA 评估) 上导致 SG 指数受损。与氯胺酮引起的门控障碍与分离症状之间存在适度正相关的初步证据一起,暂时支持 NMDAR 功能低下模型,该模型是精神分裂症中听觉 SG 障碍的基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验